Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Prosthetic Heart Valve Market – Insights

Mechanical heart valve is an artificial heart valve implanted in the patient suffering from diseases such as aortic stenosis or mitral regurgitation. Pyrolytic carbon is used to manufacture mechanical heart valve, due to its strong and durable nature. There are two types of mechanical heart valves: mechanical aortic valve and mechanical mitral valve.

The global prosthetic heart valve market is estimated to account for US$ 21,968.6 Mn in terms of value by the end of 2027.

Global Prosthetic Heart Valve Market: Drivers

Increasing prevalence of valvular heart disease (VHD) is expected to boost growth of the global prosthetic heart valve market over the forecast period. For instance, according to the study, ‘Epidemiology and Trends of Aortic Stenosis Mortality in the United States (1999-2016)’, published in Journal of the American College of Cardiology in March 2019, aortic stenosis was associated with a mortality rate of 106.3 per 1 million persons, with highest mortality rate in non-Hispanic whites followed by Hispanics, and non-Hispanic blacks. Moreover, the study noticed increase in age-adjusted mortality between the periods.

Moreover, growing healthcare expenditure is also expected to aid in growth of the market. For instance, according to the Centers for Medicare & Medicaid Services (CMS), health spending in the U.S. is projected to grow at an average rate of 5.5% per year for 2018-27 and to reach nearly US$ 6.0 trillion by 2027.     

North America region held dominant position in the global prosthetic heart valve market in 2019, accounting for 41.8% share in terms of value, followed by Europe.

Figure 1. Global Prosthetic Heart Valve Market Share (%), by Region, 2019

Prosthetic Heart Valves  | Coherent Market Insights

Global Prosthetic Heart Valve Market: Restraints

High cost of transcatheter heart valve products is expected to hinder growth of the global prosthetic heart valve market. For instance, the average cost of transcatheter aortic valve replacement (TAVR) devices is around US$ 32,000 as compared to US$ 4,000–US$ 7,000 for surgical valve devices and the average cost of TAVR and surgical procedure is US$ 37,900 and US$ 14,200, respectively.

Moreover, complications related to procedures are also expected to limit growth of the market.  TAVR carries a risk of complications that may include, bleeding, stroke, blood vessel complications, kidney disease, heart rhythm abnormalities (arrhythmias), heart attack, and infection.

Global Prosthetic Heart Valve Market: Opportunities 

Survival rate is high for mitral valve replacement among geriatric population suffering from valvular heart diseases, which is expected to increase demand for advanced prosthetic mitral valve implantation devices, thereby offering lucrative growth opportunities for players in the market.

Pregnant women treated with prosthetic mechanical heart valve are at high risk of complications such as thromboembolism during anticoagulation therapy. Therefore, manufacturers can focus on developing alternative prosthetic heart valve, which do not require anticoagulation therapy treatment after implantation for pregnant women.

Prosthetic Heart Valves  | Coherent Market Insights

Mechanical Heart Valves segment in the global prosthetic heart valve market was valued at US$ 2,476.9 Mn in 2019 and is expected to reach US$ 5,593.4 Mn by 2027 at a CAGR of 10.7% during the forecast period.

Market Trends/Key Takeaways

The market is witnessing R&D for increasing the durability of prosthetic heart valves. For instance, in October 2019, California Institute of Technology and Foldax reported development of the Tria heart valve that integrates LifePolymer, an advanced biopolymer material, and a patented bio-inspired design in order to offer a heart valve capable of lasting for 15 years without calcification, risk of clotting, or damage to red blood cells.

Increasing geriatric population in both developed and emerging economies is contributing to growth of the market. For instance, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035.

Value Chain Analysis –

Prosthetic Heart Valves  | Coherent Market Insights

Prosthetic Heart Valves  | Coherent Market Insights

Global Prosthetic Heart Valve Market: Competitive Landscape  

Major players operating in the global prosthetic heart valve market include, Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.

Global Prosthetic Heart Valve Market: Key Developments

Major players in the market are focused on product approval and launch to expand their product portfolio. For instance, in November 2019, Edwards Lifesciences Corporation received CE Mark for Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients diagnosed with aortic stenosis who are at low risk for open-heart surgery.

In April 2019, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge Aortic Valve System.

Mechanical heart valve is an artificial heart valve implanted in the patient suffering from diseases such as aortic stenosis or mitral regurgitation. There are two types of mechanical heart valves: mechanical aortic valve and mechanical mitral valve. Mechanical heart valve is the most widely used prosthetic heart valve for the treatment of patients suffering from valvular heart disease. Increasing number of heart valve implantation procedures is expected to propel growth of the global prosthetic heart valve market over the forecast period. Moreover, growing healthcare expenditure and increasing number of mitral valve replacement in population suffering from valvular heart diseases is also anticipated to assist the growth of the market during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the Prosthetic Heart Valve market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Prosthetic Heart Valve market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Edwards Lifesciences Corporation, Medtronic plc. , Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Prosthetic Heart Valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Prosthetic Heart Valve market

Detailed Segmentation:

  • Prosthetic Heart Valve Market, By Product Type:
    • Mechanical Heart Valves
      • Mechanical Aortic Valve
      • Mechanical Mitral Valve
    • Biological/Tissue Heart Valves
      • Tissue Aortic Valve
      • Tissue Mitral Valve
    • Transcatheter Heart Valves
      • Transcatheter Aortic Valve
      • Transcatheter Mitral Valve
  • Prosthetic Heart Valve Market, By End User:
    • Hospitals
    • Ambulatory Surgery Centres
  • Prosthetic Heart Valve Market, By Region:
    • North America
      • By Product Type:
        • Mechanical Heart Valves
          • Mechanical Aortic Valve
          • Mechanical Mitral Valve
        • Biological/Tissue Heart Valves
          • Tissue Aortic Valve
          • Tissue Mitral Valve
        • Transcatheter Heart Valves
          • Transcatheter Aortic Valve
          • Transcatheter Mitral Valve
      • By End User
        • Hospitals
        • Ambulatory Surgery Centres
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Mechanical Heart Valves
          • Mechanical Aortic Valve
          • Mechanical Mitral Valve
        • Biological/Tissue Heart Valves
          • Tissue Aortic Valve
          • Tissue Mitral Valve
        • Transcatheter Heart Valves
          • Transcatheter Aortic Valve
          • Transcatheter Mitral Valve
      • By End User
        • Hospitals
        • Ambulatory Surgery Centres
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Mechanical Heart Valves
          • Mechanical Aortic Valve
          • Mechanical Mitral Valve
        • Biological/Tissue Heart Valves
          • Tissue Aortic Valve
          • Tissue Mitral Valve
        • Transcatheter Heart Valves
          • Transcatheter Aortic Valve
          • Transcatheter Mitral Valve
      • By End User
        • Hospitals
        • Ambulatory Surgery Centres
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Mechanical Heart Valves
          • Mechanical Aortic Valve
          • Mechanical Mitral Valve
        • Biological/Tissue Heart Valves
          • Tissue Aortic Valve
          • Tissue Mitral Valve
        • Transcatheter Heart Valves
          • Transcatheter Aortic Valve
          • Transcatheter Mitral Valve
      • By End User
        • Hospitals
        • Ambulatory Surgery Centres
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Mechanical Heart Valves
          • Mechanical Aortic Valve
          • Mechanical Mitral Valve
        • Biological/Tissue Heart Valves
          • Tissue Aortic Valve
          • Tissue Mitral Valve
        • Transcatheter Heart Valves
          • Transcatheter Aortic Valve
          • Transcatheter Mitral Valve
      • By End User
        • Hospitals
        • Ambulatory Surgery Centres
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Mechanical Heart Valves
          • Mechanical Aortic Valve
          • Mechanical Mitral Valve
        • Biological/Tissue Heart Valves
          • Tissue Aortic Valve
          • Tissue Mitral Valve
        • Transcatheter Heart Valves
          • Transcatheter Aortic Valve
          • Transcatheter Mitral Valve
      • By End User
        • Hospitals
        • Ambulatory Surgery Centres
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Edwards Lifesciences Corporation *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Medtronic plc.
    • Boston Scientific Corporation
    • Abbott Laboratories
    • LivaNova PLC
    • CryoLife, Inc.
    • Braile Biomedica
    • Colibri Heart Valve, LLC
    • JenaValve Technology, Inc.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippets, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Prosthetic Heart Valve Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Mechanical Heart Valves
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Mechanical Aortic Valve
        • Mechanical Mitral Valve
    • Biological/Tissue Heart Valves
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Tissue Aortic Valve
        • Tissue Mitral Valve
    • Transcatheter Heart Valves
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Transcatheter Aortic Valve
        • Transcatheter Mitral Valve
  5. Global Prosthetic Heart Valve Market, By End User, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Prosthetic Heart Valve Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Company Profiles
      • Edwards Lifesciences Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • LivaNova PLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • CryoLife, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Braile Biomedica
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Colibri Heart Valve, LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • JenaValve Technology, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14figures on “Prosthetic Heart Valve Market - Global forecast to 2027”.

Frequently Asked Questions

The global prosthetic heart valves market is estimated to surpass US$ 21,968.6 Million by 2027
Major players operating in the global prosthetic heart valves market include Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.
High cost of transcatheter heart valve productsis one of the major factors that is expected to hamper growth of the market over the forecast period
Increasing prevalence of valvular heart disease (VHD)is one of the major factors that is expected to propel growth of the market over the forecast period
Development of size-adjustable prosthetic heart valve is one of the major trends that has been observed in the market.
Among regions, North America held dominant position in the global prosthetic heart valve market in 2019, accounting for 41.8% share in terms of value, followed by Europe.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner